IN2014DN10706A - - Google Patents

Info

Publication number
IN2014DN10706A
IN2014DN10706A IN10706DEN2014A IN2014DN10706A IN 2014DN10706 A IN2014DN10706 A IN 2014DN10706A IN 10706DEN2014 A IN10706DEN2014 A IN 10706DEN2014A IN 2014DN10706 A IN2014DN10706 A IN 2014DN10706A
Authority
IN
India
Prior art keywords
skin patch
improved
drug
adhesive strength
organic solvent
Prior art date
Application number
Other languages
English (en)
Inventor
Hidetoshi Hamamoto
Katsuhiro Yamanaka
Takahiro Tanimoto
Original Assignee
Medrx Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49768781&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DN10706(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medrx Co Ltd filed Critical Medrx Co Ltd
Publication of IN2014DN10706A publication Critical patent/IN2014DN10706A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN10706DEN2014 2012-06-20 2013-06-18 IN2014DN10706A (cg-RX-API-DMAC10.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012139215 2012-06-20
PCT/JP2013/066765 WO2013191187A1 (ja) 2012-06-20 2013-06-18 薬剤と有機溶媒と親油性膏体基剤と粉体を配合した貼付製剤組成物

Publications (1)

Publication Number Publication Date
IN2014DN10706A true IN2014DN10706A (cg-RX-API-DMAC10.html) 2015-09-04

Family

ID=49768781

Family Applications (1)

Application Number Title Priority Date Filing Date
IN10706DEN2014 IN2014DN10706A (cg-RX-API-DMAC10.html) 2012-06-20 2013-06-18

Country Status (16)

Country Link
US (2) US10543275B2 (cg-RX-API-DMAC10.html)
EP (1) EP2865376B2 (cg-RX-API-DMAC10.html)
JP (1) JP6309892B2 (cg-RX-API-DMAC10.html)
CN (3) CN108553452A (cg-RX-API-DMAC10.html)
AU (1) AU2013278403B2 (cg-RX-API-DMAC10.html)
BR (1) BR112014031701A2 (cg-RX-API-DMAC10.html)
CA (1) CA2875454C (cg-RX-API-DMAC10.html)
DK (1) DK2865376T4 (cg-RX-API-DMAC10.html)
ES (1) ES2738303T5 (cg-RX-API-DMAC10.html)
HU (1) HUE045479T2 (cg-RX-API-DMAC10.html)
IN (1) IN2014DN10706A (cg-RX-API-DMAC10.html)
PL (1) PL2865376T5 (cg-RX-API-DMAC10.html)
PT (1) PT2865376T (cg-RX-API-DMAC10.html)
SI (1) SI2865376T1 (cg-RX-API-DMAC10.html)
TR (1) TR201911328T4 (cg-RX-API-DMAC10.html)
WO (1) WO2013191187A1 (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9980920B2 (en) * 2013-09-11 2018-05-29 Medrx Co., Ltd. Base composition for tape agent
CN103830206B (zh) * 2014-02-26 2016-08-31 上海现代药物制剂工程研究中心有限公司 阿戈美拉汀三维网状立体构型的透皮给药制剂及制备方法
US10045948B2 (en) 2014-02-27 2018-08-14 Medrx Co., Ltd. Pramipexole-containing transdermal patch for treatment of neurodegenerative disease
WO2016109483A1 (en) * 2014-12-30 2016-07-07 Noven Pharmaceuticals, Inc. Transdermal drug delivery systems for agomelatine
WO2017037812A1 (ja) * 2015-08-29 2017-03-09 株式会社メドレックス 酸捕捉剤を含有する貼付製剤
CN107427509B (zh) * 2015-08-29 2021-06-15 美德阿利克斯株式会社 含有碱性药物和山梨酸的经皮吸收组成物
ES2957234T3 (es) 2016-03-24 2024-01-15 Medrx Co Ltd Preparación de parche con características de prevención del uso incorrecto de sustancias
CN109923186A (zh) * 2016-11-09 2019-06-21 株式会社可乐丽 粘合片、橡皮膏及它们的制造方法
CN113164423A (zh) * 2018-10-04 2021-07-23 美德阿利克斯株式会社 用非水溶剂稳定化的制剂
JPWO2022173006A1 (cg-RX-API-DMAC10.html) * 2021-02-12 2022-08-18
JP7179212B1 (ja) 2022-05-02 2022-11-28 久光製薬株式会社 リドカイン含有貼付剤

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3144895B2 (ja) 1992-06-30 2001-03-12 積水化学工業株式会社 医療用粘着テープもしくはシート
JPH06145050A (ja) 1992-11-11 1994-05-24 Sekisui Chem Co Ltd 貼付剤の製造方法
JPH07145047A (ja) 1993-11-25 1995-06-06 Sekisui Chem Co Ltd 局所麻酔用経皮吸収テープ
JPH0827003A (ja) 1994-07-22 1996-01-30 Sekisui Chem Co Ltd 経皮吸収製剤
JPH09169636A (ja) 1995-06-12 1997-06-30 Sekisui Chem Co Ltd 貼付剤
JPH09136834A (ja) 1995-11-14 1997-05-27 Sekisui Chem Co Ltd 経皮吸収貼付剤
JP4648518B2 (ja) * 2000-06-01 2011-03-09 帝國製薬株式会社 4−ビフェニル酢酸含有貼付剤
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
US6503532B1 (en) 2001-04-13 2003-01-07 Murty Pharmaceuticals, Inc. Pharmaceutical composition containing tetrahydrocannabinol and a transdermal/transcutaneous delivery method thereof
AU2003272878A1 (en) * 2002-09-13 2004-04-30 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
KR20050092429A (ko) * 2003-01-22 2005-09-21 니찌방 가부시기가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법
US8080261B2 (en) * 2004-09-30 2011-12-20 Teikoku Pharma Usa, Inc. 1-chloro-2,4-dinitrobenzene non-aqueous gel compositions and methods for using the same
WO2008032719A1 (en) 2006-09-11 2008-03-20 Sekisui Chemical Co., Ltd. Adhesive preparation
JP4148988B2 (ja) * 2006-09-11 2008-09-10 積水化学工業株式会社 貼付剤
CN103239721B (zh) * 2007-11-22 2016-03-16 美德阿利克斯株式会社 包括基于脂肪酸的离子型液体作为活性成分的外用制剂组合物
EP2258396B1 (en) 2008-03-03 2017-09-06 Hisamitsu Pharmaceutical Co., Inc. Transdermally absorbable preparation
JP4822032B2 (ja) 2009-01-08 2011-11-24 タイヨーエレック株式会社 組合せ式遊技機
WO2010113225A1 (en) * 2009-03-30 2010-10-07 Yutoku Pharmaceutical Industries Co., Ltd. Riluzole-containing transdermal patch
DE102009022915A1 (de) * 2009-05-27 2010-12-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit gesteuertem Wirkstofffluss
JP2011074035A (ja) 2009-09-30 2011-04-14 Sekisui Medical Co Ltd 貼付剤

Also Published As

Publication number Publication date
PL2865376T3 (pl) 2019-12-31
AU2013278403A1 (en) 2015-01-22
DK2865376T4 (da) 2022-07-18
JPWO2013191187A1 (ja) 2016-05-26
WO2013191187A1 (ja) 2013-12-27
BR112014031701A2 (pt) 2017-06-27
EP2865376B2 (en) 2022-05-11
JP6309892B2 (ja) 2018-04-11
US20150174249A1 (en) 2015-06-25
ES2738303T5 (es) 2022-09-12
HUE045479T2 (hu) 2019-12-30
AU2013278403B2 (en) 2018-02-01
SI2865376T1 (sl) 2019-11-29
US10543275B2 (en) 2020-01-28
CN110693859A (zh) 2020-01-17
ES2738303T3 (es) 2020-01-21
CN108553452A (zh) 2018-09-21
PT2865376T (pt) 2019-08-26
EP2865376A4 (en) 2015-11-18
TR201911328T4 (tr) 2019-08-21
EP2865376B1 (en) 2019-06-05
US12016924B2 (en) 2024-06-25
EP2865376A1 (en) 2015-04-29
DK2865376T3 (da) 2019-08-12
CA2875454A1 (en) 2013-12-27
CA2875454C (en) 2021-02-16
PL2865376T5 (pl) 2023-01-09
CN104363900A (zh) 2015-02-18
US20190388544A1 (en) 2019-12-26

Similar Documents

Publication Publication Date Title
BR112014031701A2 (pt) composição para a preparação de um emplastro não aquoso
IN2015DN00544A (cg-RX-API-DMAC10.html)
HK1213264A1 (zh) 经取代的苯化合物
EP3622947B8 (en) Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
WO2013142611A3 (en) Silk reservoirs for drug delivery
PL2869854T3 (pl) Kompozycja do promowania regeneracji uszkodzonej tkanki ciała zawierająca ektoinę lub hydroksyektoinę jako substancję czynną
HRP20160888T1 (hr) Postupak za pripremanje vodene otopine koja sadrži barem jedan zemnoalkalijski hidrogenkarbonat te njezina uporaba
IL233497A0 (en) A process for preparing an aqueous solution containing at least one trace alkali hydrogen carbonate and its use
AU2012265219A8 (en) Compounds containing hydrido-tricyano-borate anions
IN2015DN01165A (cg-RX-API-DMAC10.html)
UA109144C2 (ru) Дезинфицирующий и антисептический препарат с пониженным содержанием йода
FI20120287A7 (fi) Hartsihappoja sisältävä vesikoostumus käytettäväksi antimikrobisena hoitoaineena ja lisäaineena
SG10201609644UA (en) Glucokinase activator compositions for the treatment of diabetes
MX2014013829A (es) Derivados de espiro[2.4] heptano puenteados fluorados como agonistas del receptor de alx.
FI20110371L (fi) Veden pihkaseoskoostumus (dispersio) käytettäväksi antimikrobisena lääketieteellisenä hoitoaineena ja antimikrobisena lisäaineena vesiohenteisissa liuoksissa sekä teknillisissä materiaaleissa
MX359713B (es) Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas.
WO2012063498A3 (ja) 新規なエキセメスタン固体分散体
AP2012006545A0 (en) Electrochemically activated waterbased solution and use of the solution
MX2016009458A (es) Solucion alcoholica estable de alprostadilo.
CL2014003282A1 (es) Uso de cetal como solvente en adhesivos y composición adhesiva que contiene cetal.
ZA201405920B (en) Process for the preparation of an aqueous solution comprising at least one earth alkali hydrogen carbonate and its use
ZA201405302B (en) Process for the preparation of an aqueous solution comprising at least one earth alkali hydrogen carbonate and its use
ZA201407279B (en) Aqueous compositions containing the potassium salt of (s)-(+)-abscisic acid